Developing Integrated Extended Pharmacist Roles and Services for Equitable Access and Outcomes in Primary Healthcare: A Realist Evaluation

Articles in Press

Document Type : Original Article

Authors

1 School of Nursing, Midwifery, and Health Practice, Victoria University of Wellington, Wellington, New Zealand

2 Health Services Research Centre, Victoria University of Wellington, Wellington, New Zealand

3 Department of Primary Health Care & General Practice, University of Otago, Wellington, New Zealand

4 Centre for Interprofessional Education, Division of Health Sciences, University of Otago, Dunedin, New Zealand

Abstract

Background 
Pharmacists’ roles have been moving from dispensing towards more patient-focused extended clinical care, signalling changes in health service policy and delivery. This paper evaluates the development of practice pharmacists’ roles and services in primary healthcare (PHC) settings in New Zealand (Aotearoa), how services were implemented, and how pharmacists, patients, and other PHC professionals responded to role and service developments.
 
Methods 
We applied a realist evaluation methodology, identifying context (C) into which initiatives are introduced, mechanism (M) triggered or attenuated by the context, and resulting outcome (O). CMO configurations were developed, tested and refined through rapid realist review, key informant interviews, six case studies, and a national survey. Although not every project stage is fully documented in this paper, each contributed to the final theories. The desired outcome was defined as: Practice pharmacists are integrated within PHC teams, and their services are accepted and utilised by patients. Practice pharmacist services are equitably accessible throughout Aotearoa and contribute to equitable health outcomes.
 
Results 
Four programme theories, based on 22 CMO configurations, showed how contexts and mechanisms at national, service, role, and patient levels could enable or attenuate reaching the desired outcome; for example, through a burning platform for change, supportive colleagues and infrastructure, well-fitting roles, and patient awareness, or conversely through, disjointed leadership, limited understanding and role uncertainty, and lack of access to practice pharmacists. Funding, regardless of source, operated across all levels as context and mechanism.
 
Conclusion 
Practice pharmacist services operate within multiple contexts and levels; their development and implementation requires a systems view. Opportunities exist to achieve the desired outcome by strengthening enabling contexts or reducing barriers within attenuating contexts. Policy-makers now need to focus on equitable service distribution, sustainable ways to fund and employ practice pharmacists, and the equity impact of patient copayments.

Keywords

References

  1. Tsuyuki R, Bond C. The evolution of pharmacy practice research-part I: time to implement the evidence. Int J Pharm Pract. 2019;27(2):109-111. doi:1111/ijpp.12527
  2. Khaira M, Mathers A, Benny Gerard N, Dolovich L. The evolving role and impact of integrating pharmacists into primary care teams: experience from Ontario, Canada. Pharmacy (Basel). 2020;8(4):234. doi:3390/pharmacy8040234
  3. Mann C, Anderson C, Avery AJ, Waring J, Boyd M. Clinical Pharmacists in General Practice: Pilot Scheme: Independent Evaluation Report: Full Report. Nottingham: University of Nottingham; 2018.
  4. Stewart D, Maclure K, Newham R, et al. A cross-sectional survey of the pharmacy workforce in general practice in Scotland. Fam Pract. 2020;37(2):206-212. doi:1093/fampra/cmz052
  5. Sudeshika T, Naunton M, Deeks LS, Thomas J, Peterson GM, Kosari S. General practice pharmacists in Australia: a systematic review. PLoS One. 2021;16(10):e0258674. doi:1371/journal.pone.0258674
  6. Haua R, Harrison J, Aspden T. Pharmacist integration into general practice in New Zealand. J Prim Health Care. 2019;11(2):159-169. doi:1071/hc18103
  7. Dodd MA, Haines SL, Maack B, et al. ASHP statement on the role of pharmacists in primary care. Am J Health Syst Pharm. 2022;79(22):2070-2078. doi:1093/ajhp/zxac227
  8. Freeman C, Rigby D, Aloizos J, Williams I. The practice pharmacist: a natural fit in the general practice team. Aust Prescr. 2016;39(6):211-214. doi:18773/austprescr.2016.067
  9. Benson H, Lucas C, Benrimoj SI, Williams KA. The development of a role description and competency map for pharmacists in an interprofessional care setting. Int J Clin Pharm. 2019;41(2):391-407. doi:1007/s11096-019-00808-4
  10. NHS England. Independent Prescribing. https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-integration-fund/independent-prescribing/. Accessed September 2, 2025.
  11. General Pharmaceutical Council. Standards for the Education and Training of Pharmacist Independent Prescribers. https://assets.pharmacyregulation.org/files/document/standards-for-the-education-and-training-of-pharmacist-independent-prescribers-october-2022.pdf. Updated October, 2022. Accessed September 2, 2025.
  12. Leong SL, Teoh SL, Fun WH, Lee SW. Task shifting in primary care to tackle healthcare worker shortages: an umbrella review. Eur J Gen Pract. 2021;27(1):198-210. doi:1080/13814788.2021.1954616
  13. Hazen A, Sloeserwij V, Pouls B, et al. Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care. Int J Clin Pharm. 2021;43(5):1155-1162. doi:1007/s11096-021-01304-4
  14. Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608-622. doi:1016/j.sapharm.2013.08.006
  15. Syafhan NF, Al Azzam S, Williams SD, et al. General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial. J Pharm Policy Pract. 2021;14(1):4. doi:1186/s40545-020-00279-3
  16. Komwong D, Greenfield G, Zaman H, Majeed A, Hayhoe B. Clinical pharmacists in primary care: a safe solution to the workforce crisis? J R Soc Med. 2018;111(4):120-124. doi:1177/0141076818756618
  17. Sim TF, Hattingh HL, Sunderland B, Czarniak P. Effective communication and collaboration with health professionals: a qualitative study of primary care pharmacists in Western Australia. PLoS One. 2020;15(6):e0234580. doi:1371/journal.pone.0234580
  18. Fazel MT, Bagalagel A, Lee JK, Martin JR, Slack MK. Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis. Ann Pharmacother. 2017;51(10):890-907. doi:1177/1060028017711454
  19. Desse TA, Vakil K, Mc Namara K, Manias E. Impact of clinical pharmacy interventions on health and economic outcomes in type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2021;38(6):e14526. doi:1111/dme.14526
  20. Alshehri AA, Jalal Z, Cheema E, Haque MS, Jenkins D, Yahyouche A. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: a systematic review and meta-analysis of randomised controlled trials. Br J Clin Pharmacol. 2020;86(1):29-38. doi:1111/bcp.14164
  21. Dawoud DM, Haines A, Wonderling D, et al. Cost effectiveness of advanced pharmacy services provided in the community and primary care settings: a systematic review. Pharmacoeconomics. 2019;37(10):1241-1260. doi:1007/s40273-019-00814-4
  22. Phimarn W, Saramunee K, Leelathanalerk A, et al. Economic evaluation of pharmacy services: a systematic review of the literature (2016-2020). Int J Clin Pharm. 2023;45(6):1326-1348. doi:1007/s11096-023-01590-0
  23. Claire M, Claire A, Matthew B. The role of clinical pharmacists in general practice in England: impact, perspectives, barriers and facilitators. Res Social Adm Pharm. 2022;18(8):3432-3437. doi:1016/j.sapharm.2021.10.006
  24. Karampatakis GD, Patel N, Stretch G, Ryan K. Patients' experiences of pharmacists in general practice: an exploratory qualitative study. BMC Fam Pract. 2021;22(1):48. doi:1186/s12875-021-01393-0
  25. Mann C, Anderson C, Boyd M, Karsan Y, Emerson T. Perspectives of pharmacists in general practice from qualitative focus groups with patients during a pilot study. BJGP Open. 2022;6(2):BJGPO.2021.0112. doi:3399/bjgpo.2021.0112
  26. James O, Cardwell K, Moriarty F, Smith SM, Clyne B. Pharmacists in general practice: a qualitative process evaluation of the General Practice Pharmacist (GPP) study. Fam Pract. 2020;37(5):711-718. doi:1093/fampra/cmaa044
  27. Nelson PA, Bradley F, Martindale AM, McBride A, Hodgson D. Skill-mix change in general practice: a qualitative comparison of three 'new' non-medical roles in English primary care. Br J Gen Pract. 2019;69(684):e489-e498. doi:3399/bjgp19X704117
  28. Ministry of Health. Pharmacy Action Plan: 2016 to 2020. Wellington: Ministry of Health; 2016.
  29. Pharmaceutical Society of New Zealand, New Zealand Medical Association. An Integrated Health Care Framework for Pharmacists and Doctors. 2017. https://www.psnz.org.nz/Folder?Action=View%20File&Folder_id=86&File=IntegratedHealthCareFramework_Final.pdf. Accessed September 2, 2025.
  30. Minister of Health. New Zealand Health Strategy. Wellington: Ministry of Health; 2023.
  31. New Zealand Ministry for Culture and Heritage. Treaty of Waitangi. https://nzhistory.govt.nz/politics/treaty-of-waitangi. Accessed September 2, 2025.
  32. Manatū Hauora | Ministry of Health. Te Tiriti o Waitangi Framework. 2024. https://www.health.govt.nz/maori-health/te-tiriti-o-waitangi-framework. Updated May 6, 2024. Accessed September 2, 2025.
  33. Cumming J. New Zealand Health System Review. New Delhi: World Health Organization Regional Office for South-East Asia; 2022.
  34. Health New Zealand | Te Whatu Ora. Organisational Overview. Health New Zealand. https://www.tewhatuora.govt.nz/corporate-information/our-health-system/organisational-overview/. Accessed September 2, 2025.
  35. Health New Zealand | Te Whatu Ora. Primary Health Organisations. Health New Zealand. https://www.tewhatuora.govt.nz/for-health-providers/primary-care-sector/primary-health-organisations. Updated November 19, 2024. Accessed September 2, 2025.
  36. Health New Zealand | Te Whatu Ora. Community Services Card. Health New Zealand. https://www.tewhatuora.govt.nz/for-health-providers/claims-provider-payments-and-entitlements/community-services-card/. Updated January 3, 2024. Accessed September 2, 2025.
  37. Health New Zealand | Te Whatu Ora. Capitation Rates. Health New Zealand. https://www.tewhatuora.govt.nz/for-health-providers/primary-care-sector/capitation-rates. Updated July 16, 2025. Accessed August 25, 2025.
  38. Health New Zealand | Te Whatu Ora. Services to Improve Access. Health New Zealand. https://www.tewhatuora.govt.nz/for-health-providers/claims-provider-payments-and-entitlements/services-to-improve-access/#very-low-cost-access-scheme. Updated September 27, 2024. Accessed September 2, 2025.
  39. Pharmacy Council of New Zealand | Te Pou Whakamana Kaimatū o Aotearoa. Position Statement: Council Expectations for Pharmacists Practising in Clinical Roles in General Practice. Wellington: PCNZ; 2019.
  40. Clinical Advisory Pharmacists Association (CAPA). Service Development Toolkit for General Practice Based Clinical Pharmacists. CAPA; 2019.
  41. Pharmacy Council of New Zealand | Te Pou Whakamana Kaimatū o Aotearoa. Pharmacy Workforce Demographic 2024. https://pharmacycouncil.org.nz/wp-content/uploads/2024/09/2024-Demographic-Report.pdf. Accessed September 2, 2025.
  42. Cardwell K, Smith SM, Clyne B, et al. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study. BMJ Open. 2020;10(6):e035087. doi:1136/bmjopen-2019-035087
  43. Haua RJ. Evaluating Models of Pharmacist Integration into General Practice in New Zealand [PhD thesis]. Auckland, NZ: University of Auckland; 2023.
  44. Officer T, Cumming J, McBride-Henry K. Successfully developing advanced practitioner roles: policy and practice mechanisms. J Health Organ Manag. 2019;33(1):63-77. doi:1108/jhom-02-2018-0064
  45. Boyina SY, Stokes T, Renall A, Braund R. Clinical pharmacist facilitators in primary care: a descriptive study of their roles and services provided in general practices of southern New Zealand. J Prim Health Care. 2020;12(1):88-95. doi:1071/hc19073
  46. McDonald J, Morris C, Officer TN, et al. Practice pharmacists in the primary healthcare team in Aotearoa New Zealand: a national survey. J Prim Health Care. 2024;16(4):332-340. doi:1071/HC24049.
  47. Royal New Zealand College of General Practitioners (RNZCGP). Ngā Kaitaka Rongoā i rō whare tākuta: Pharmacists in General Practice. Wellington: RNZCGP; 2023. https://www.rnzcgp.org.nz/documents/222/CGP015_Pharmacists_in_GP_Report_4_2A.pdf. Accessed September 2, 2025.
  48. Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061. doi:1136/bmj.n2061
  49. Pawson R, Tilley N. Realistic Evaluation. London: SAGE Publications; 1997.
  50. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist Synthesis: An Introduction. Better Evaluation; 2004. https://www.betterevaluation.org/en/resources/guide/realist_synthesis_an_introduction. Accessed September 2, 2025.
  51. RAMESES Projects. What Realists Mean by Context; Or, Why Nothing Works Everywhere or for Everyone (The RAMESES II Project). 2017. http://www.ramesesproject.org/media/RAMESES_II_Context.pdf. Accessed September 2, 2025.
  52. RAMESES Projects. What is a Mechanism? What is a Programme Mechanism? (The RAMESES II Project). 2017. http://www.ramesesproject.org/media/RAMESES_II_What_is_a_mechanism.pdf. Accessed September 2, 2025.
  53. Pawson R, Manzano-Santaella A. A realist diagnostic workshop. Evaluation. 2012;18(2):176-191. doi:1177/1356389012440912
  54. Ministry of Health. Implementing Medicines New Zealand 2015 to 2020. 2015. https://www.health.govt.nz/publications/implementing-medicines-new-zealand-2015-to-2020. Accessed September 2, 2025.
  55. Health and Disability System Review. Health and Disability System Review - Final Report. 2020. https://www.health.govt.nz/publications/health-and-disability-system-review-final-report. Accessed September 2, 2020.
  56. Morris C, McDonald J, Officer TN, et al. A realist evaluation of the development of extended pharmacist roles and services in community pharmacies. Res Social Adm Pharm. 2024;20(3):321-334. doi:1016/j.sapharm.2023.11.006.
  57. Lumivero. NVivo 14. 2025. https://lumivero.com/products/nvivo/. Accessed September 2, 2025.
  58. Healthify He Puna Waiora. Health Improvement Practitioner. https://healthify.nz/hauora-wellbeing/h/health-improvement-practitioner/. Updated June 28, 2023. Accessed September 2, 2025.
  59. Collaborative Aotearoa. Health Care Home. https://healthcarehome.org.nz/. Accessed September 2, 2025.
  60. Middleton L, Dunn P, O’Loughlin C, Cumming J. Taking Stock: Primary Care Innovation. Wellington, NZ: Victoria University of Wellington, Health Services Research Centre; 2018.
  61. Noble C, McKauge L, Clavarino A. Pharmacy student professional identity formation: a scoping review. Integr Pharm Res Pract. 2019;8:15-34. doi:2147/iprp.S162799
  62. Hopkinson J. Applications Open for Funded Pharmacist Prescriber Programmes. NZ Doctor; 2024. https://www.nzdoctor.co.nz/article/news/applications-open-funded-pharmacist-prescriber-programmes.
  63. Health New Zealand | Te Whatu Ora. Comprehensive Primary and Community Care Teams. 2024. https://www.tewhatuora.govt.nz/health-services-and-programmes/primary-community-and-rural-early-actions-programme/comprehensive-primary-and-community-care-teams/. Updated May 20, 2025. Accessed September 2, 2025.
  64. Cassie F. No Timeline for Comprehensive Teams Review or Minister’s Mooted Community Cancer Infusions. NZ Doctor; 2024. https://www.nzdoctor.co.nz/article/news/no-timeline-comprehensive-teams-review-or-ministers-mooted-community-cancer-infusions.
  65. Akhtar N, Hasan SS, Babar ZU. Evaluation of general practice pharmacists’ role by key stakeholders in England and Australia. J Pharm Health Serv Res. 2022;13(1):31-40. doi:1093/jphsr/rmac002
  66. Hurley E, Gleeson LL, Byrne S, Walsh E, Foley T, Dalton K. General practitioners' views of pharmacist services in general practice: a qualitative evidence synthesis. Fam Pract. 2022;39(4):735-746. doi:1093/fampra/cmab114
  67. Ryan K, Patel N, Lau WM, Abu-Elmagd H, Stretch G, Pinney H. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation. BMC Health Serv Res. 2018;18(1):234. doi:1186/s12913-018-3056-3
  68. Sudeshika T, Naunton M, Peterson GM, et al. Interprofessional collaboration and team effectiveness of pharmacists in general practice: a cross-national survey. Int J Environ Res Public Health. 2022;20(1):394. doi:3390/ijerph20010394
  69. Bradley F, Nelson PA, Cutts C, Hodgson D. Negotiating new roles in general practice: a qualitative study of clinical pharmacists. Br J Gen Pract. 2024;74(738):e27-e33. doi:3399/bjgp.2023.0145
  70. Bartlett S, Bullock A, Morris F. 'It's the stuff they can do better than us': case studies of general practice surgeries' experiences of optimising the skill-mix contribution of practice-based pharmacists in Wales. BMJ Open. 2023;13(11):e073778. doi:1136/bmjopen-2023-073778
  71. Pullon S, Morgan S, Macdonald L, McKinlay E, Gray B. Observation of interprofessional collaboration in primary care practice: a multiple case study. J Interprof Care. 2016;30(6):787-794. doi:1080/13561820.2016.1220929
  72. Pharmacy Council of New Zealand | Te Pou Whakamana Kaimatū o Aotearoa. Pharmacist Prescribers. 2025. https://pharmacycouncil.org.nz/pharmacist/pharmacist-prescribers/. Accessed September 2, 2025.
  73. Parejo L, Jones T. Embedding pharmacist prescribing into undergraduate pharmacist education: a qualitative analysis of student and stakeholder perspectives. Int J Pharm Pract. 2023;31(Suppl 2):ii41-ii42. doi:1093/ijpp/riad074.051
  74. Bader LR, Bates I, Galbraith K. Trends in advanced practice and specialisation in the global pharmacy workforce: a synthesis of country case studies. Int J Pharm Pract. 2020;28(2):182-190. doi:1111/ijpp.12612
  75. Stats NZ. 2023 Census Population Counts (By Ethnic Group, Age, and Māori Descent) and Dwelling Counts. 2024. https://www.stats.govt.nz/information-releases/2023-census-population-counts-by-ethnic-group-age-and-maori-descent-and-dwelling-counts/. Accessed September 2, 2025.
  76. University of Auckland. About MAPAS. https://www.auckland.ac.nz/en/fmhs/study-with-us/maori-and-pacific-at-the-faculty/maori-and-pacific-admission-schemes.html. Accessed September 2, 2025.
  77. University of Otago. Te Kauae Parāoa: Division of Health Sciences Policy on Admissions. https://www.otago.ac.nz/healthsciences/staff/te-kauae-paraoa. 2025. Accessed September 2, 2025.
  78. Alshehri AA, Hindi AMK, Cheema E, Sayeed Haque M, Jalal Z, Yahyouche A. Integration of pharmacist independent prescribers into general practice: a mixed-methods study of pharmacists' and patients' views. J Pharm Policy Pract. 2023;16(1):10. doi:1186/s40545-023-00520-9
  79. Anderson C, Zhan K, Boyd M, Mann C. The role of pharmacists in general practice: a realist review. Res Social Adm Pharm. 2019;15(4):338-345. doi:1016/j.sapharm.2018.06.001
  80. World Health Organization (WHO). Framework for Action on Interprofessional Education and Collaborative Practice. Geneva: WHO; 2010. https://www.who.int/publications/i/item/framework-for-action-on-interprofessional-education-collaborative-practice. Accessed September 2, 2025.
  81. Institute of Medicine. Interprofessional Education for Collaboration: Learning How to Improve Health from Interprofessional Models Across the Continuum of Education to Practice: Workshop Summary. Washington, DC: The National Academies Press; 2013. https://nap.nationalacademies.org/catalog/13486/interprofessional-education-for-collaboration-learning-how-to-improve-health-from. Accessed September 2, 2025.
  82. Butterworth J, Sansom A, Sims L, Healey M, Kingsland E, Campbell J. Pharmacists' perceptions of their emerging general practice roles in UK primary care: a qualitative interview study. Br J Gen Pract. 2017;67(662):e650-e658. doi:3399/bjgp17X691733
  83. Deeks LS, Kosari S, Peterson GM, Sudeshika T, Naunton M. Factors contributing to pharmacists leaving employment in general practice in Australia: an exploratory study. Int J Pharm Pract. 2023;31(4):438-441. doi:1093/ijpp/riad023
  84. Chilton-Towle J. UK Pharmacists Complain of NHS Pinching Staff for General Practice. Pharmacy Today; 2022. https://www.pharmacytoday.co.nz/article/print-archive/uk-pharmacists-complain-nhs-pinching-staff-general-practice.
  85. Sudeshika T, Naunton M, Yee KC, Deeks LS, Peterson GM, Kosari S. Patients' opinions towards the services of pharmacists based in general practice. Pharmacy (Basel). 2022;10(4):78. doi:3390/pharmacy10040078
  86. McCahon D, Duncan P, Payne R, Horwood J. Patient perceptions and experiences of medication review: qualitative study in general practice. BMC Prim Care. 2022;23(1):293. doi:1186/s12875-022-01903-8
  87. Nabhani-Gebara S, Fletcher S, Shamim A, et al. General practice pharmacists in England: integration, mediation and professional dynamics. Res Social Adm Pharm. 2020;16(1):17-24. doi:1016/j.sapharm.2019.01.014
  88. Officer TN, McBride-Henry K. Perceptions of underlying practice hierarchies: who is managing my care? BMC Health Serv Res. 2021;21(1):911. doi:1186/s12913-021-06931-1
  89. Officer TN, Cumming J, McBride-Henry K. 'She taught me': factors consumers find important in nurse practitioner and pharmacist prescriber services. Hum Resour Health. 2021;19(1):41. doi:1186/s12960-021-00587-y
  90. Hasan Ibrahim AS, Barry HE, Hughes CM. GPs' and pharmacists' views of integrating pharmacists into general practices: a qualitative study. Br J Gen Pract. 2023;73(731):e407-e417. doi:3399/bjgp.2022.0518
  91. Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209-232. doi:1177/1715163514536678
  92. Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health Policy. 2010;95(1):1-9. doi:1016/j.healthpol.2009.11.008
  93. Jeffreys M, Ellison-Loschmann L, Irurzun-Lopez M, Cumming J, McKenzie F. Financial barriers to primary health care in Aotearoa New Zealand. Fam Pract. 2024;41(6):995-1001. doi:1093/fampra/cmad096
  94. Greenhalgh T, Humphrey C, Hughes J, Macfarlane F, Butler C, Pawson R. How do you modernize a health service? A realist evaluation of whole-scale transformation in London. Milbank Q. 2009;87(2):391-416. doi:1111/j.1468-0009.2009.00562.x
  95. Dalkin SM, Greenhalgh J, Jones D, Cunningham B, Lhussier M. What's in a mechanism? Development of a key concept in realist evaluation. Implement Sci. 2015;10:49. doi:1186/s13012-015-0237-x
  96. Pawson R, Tilley N. Realist Evaluation (Paper for the British Cabinet Office). 2004. https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=e092393652456869d7ccf6fa57b5a5a4d2d9e10a. Accessed September 2, 2025.
International Journal of Health Policy and Management

Articles in Press, Corrected Proof
Available Online from 15 November 2025

Files

History

  • Received Date: 01 April 2025
  • Revised Date: 02 September 2025
  • Accepted Date: 08 November 2025
  • First Published Date: 12 November 2025
  • Published Date: 15 November 2025

Share

How to cite

Statistics